SCHEMBL25820332

SCHEMBL25820332

CC(C)NS(=O)(=O)c1cc(C(C)C)ccn1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.37
SMN1; SMN2 Q16637 4/20 0.37
HPGD P15428 1/20 0.37
CHRNA7 P36544 1/20 0.37
EGFR P00533 1/20 0.36
TNNI3K Q59H18 1/20 0.36
GFER P55789 1/20 0.36
POLB P06746 1/20 0.36
PGR P06401 1/20 0.34
AURKA O14965 1/20 0.34
DAPK3 O43293 1/20 0.34
JAK2 O60674 1/20 0.34
MAP4K4 O95819 1/20 0.34
PAK4 O96013 1/20 0.34
ABL1 P00519 1/20 0.34
LCK P06239 1/20 0.34
FYN P06241 1/20 0.34
CSF1R P07333 1/20 0.34
RET P07949 1/20 0.34
IGF1R P08069 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10284897 0.79 CHRNA7 (0.40) ALDH1A1SMN1; SMN2HPGDCHRNA7EGFR
SCHEMBL14299651 0.77 CHRNA7 (0.49) ALDH1A1SMN1; SMN2HPGDCHRNA7EGFR
SCHEMBL13058695 0.76 CHRNA7 (0.39) ALDH1A1SMN1; SMN2HPGDCHRNA7EGFR
SCHEMBL25825555 0.75 EDNRA (0.42) ALDH1A1SMN1; SMN2CHRNA7GAA
SCHEMBL20889617 0.74 CHRNA7 (0.36) ALDH1A1SMN1; SMN2HPGDCHRNA7EGFR
SCHEMBL578901 0.74 L3MBTL1 (0.51) KAT6ANPSR1HTT
SCHEMBL25820335 0.73 GFER (0.46) ALDH1A1SMN1; SMN2CHRNA7GFERNPSR1
SCHEMBL12089569 0.72 CA2 (0.51) ALDH1A1SMN1; SMN2HPGDEGFRTNNI3K
SCHEMBL25824991 0.72 ALDH1A1 (0.31) ALDH1A1SMN1; SMN2HPGDCHRNA7EGFR
SCHEMBL26971207 0.72 CDK2 (0.37) ALDH1A1SMN1; SMN2HPGDCHRNA7EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219927-A1 AKT3 MODULATORS Georgiamune Inc. 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219927-A1 AKT3 MODULATORS AKT3, AKT2, PIK3CA ALDH1A1 3871/4885SMN1; SMN2 2169/4885HPGD 2768/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.